Reduced Proteasomal Activity in Marrow Cells From Myelodysplastic Syndrome (MDS) Patients.

被引：0
作者：
Karabina, Stela [1 ]
Thanopoulou, Eleni [1 ]
Athanasiou, Sotirios D. [2 ]
Symeonidis, Argiris [3 ]
Zoumbos, Nicholas [4 ]
机构：
[1] Univ Patras, Sch Med, Div Hematol, Dept Internal Med, Patras, Greece
[2] Univ Patras, Dept Chem, Biochem Lab, Patras, Greece
[3] Univ Patras, Sch Med, GR-26110 Patras, Greece
[4] Univ Patras, Rion, Greece
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：706 / 707
页数：2
相关论文
共 50 条
  • [21] THE INCIDENCE AND CLINICAL IMPLICATIONS OF CHROMOTHRIPSIS IN BONE MARROW CELLS OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Zemanova, Z.
    Michalova, K.
    Brezinova, J.
    Lhotska, H.
    Svobodova, K.
    Sarova, I.
    Lizcova, L.
    Izakova, S.
    Ransdorfova, S.
    Zdenek, K.
    Belickova, M.
    Jonasova, A.
    Siskova, M.
    Neuwirtova, R.
    Cermak, J.
    HAEMATOLOGICA, 2016, 101 : 69 - 70
  • [22] P53 AND PUMA EXPRESSIONS IN BONE MARROW BIOPSIES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)
    Bektas, O.
    Uner, A.
    Buyukasik, Y.
    Uz, B.
    Eliacik, E.
    Isik, A.
    Haznedaroglu, I.
    Goker, H.
    Demiroglu, H.
    Aksu, S.
    Ozcebe, O.
    Sayinalp, N.
    HAEMATOLOGICA, 2012, 97 : 369 - 369
  • [23] Chromosomal analysis of hematopoietic and stromal progenitor cells in patients with myelodysplastic syndrome (MDS)
    Pimenova, M.
    Kokhno, A.
    Domracheva, E.
    Drize, N.
    Manakova, T.
    Konnova, M.
    Maltseva, Y. U.
    Shishigina, L.
    Parovichnikova, E.
    Savchenko, V.
    LEUKEMIA RESEARCH, 2013, 37 : S137 - S137
  • [24] Flow cytometric analysis of apoptotic progenitor cells in patients with myelodysplastic syndrome (MDS).
    Oyake, T
    Ishida, Y
    Ito, S
    Murai, K
    Kuriya, SI
    BLOOD, 1999, 94 (10) : 286B - 286B
  • [25] Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome
    Qian, J
    Chen, ZX
    Wang, W
    Cen, HN
    Xue, YQ
    ONCOLOGY REPORTS, 2005, 14 (05) : 1189 - 1197
  • [26] CONSECUTIVE CHROMOSOMAL STUDIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)
    MICHALOVA, K
    MUSILOVA, J
    ZEMANOVA, Z
    ANNALES DE GENETIQUE, 1991, 34 (3-4): : 212 - 218
  • [27] Dynamics of the apoptotic death of bone marrow cells in myelodysplastic syndromes (MDS).
    Mundle, S
    Cartlidge, J
    Venugopal, P
    Gezer, S
    Hines, C
    Jassak, P
    Gregory, SA
    Alvi, S
    Shetty, V
    Robin, E
    Kawauchi, R
    Rifkin, S
    Alston, D
    Hernandez, B
    Shah, R
    Raza, A
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 309 - 309
  • [28] Bone Marrow Pathologic Abnormalities in Myelodysplastic Syndrome (MDS) Patients with Underlying TERT/TERC Germline Alterations
    Evans, Mark
    Khoury, Joseph
    DiNardo, Courtney
    Garcia-Manero, Guillermo
    Yang, Hui
    Loghavi, Sanam
    Montalban-Bravo, Guillermo
    Patel, Keyur
    Quesada, Andres
    Konoplev, Sergej
    Garces, Sofia
    Toruner, Gokce
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 945 - 946
  • [29] Bone Marrow Pathologic Abnormalities in Myelodysplastic Syndrome (MDS) Patients with Underlying TERT/TERC Germline Alterations
    Evans, Mark
    Khoury, Joseph
    Di Nardo, Courtney
    Garcia-Manero, Guillermo
    Yang, Hui
    Loghavi, Sanam
    Montalban-Bravo, Guillermo
    Patel, Keyur
    Quesada, Andres
    Konoplev, Sergej
    Garces, Sofia
    Toruner, Gokce
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffrey
    Kanagal-Shamanna, Rashmi
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 945 - 946
  • [30] Simultaneous detection of granulocyte abnormalities in blood and bone marrow of patients with myelodysplastic syndrome (MDS) by flow cytometry
    Beck, RC
    Maciejewski, JP
    Stahl, S
    Hsi, ED
    LABORATORY INVESTIGATION, 2005, 85 : 223A - 224A
12345